Skip to main content

Closed

NCEL: NewcelX Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-75.3%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage-15269.8×

Current ratio0.76×

NewcelX Ltd.

NCELNASDAQ Capital Market·USD·Closed

NewcelX Ltd.

NCELNASDAQ·USD·Closed

$3.49

+3.83%

$3.49

+$0.13 (3.83%)

52W Range

6thpctl

Volume

0.26×avg

Mkt Cap

1.57MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.26×avg

Market Cap

1.57MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings